| 國立臺灣大學 |
2008 |
Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
|
Tseng, Ching-Li; Wu, Steven Yueh-Hsiu; Wang, Wen-Hsi; Peng, Cheng-Liang; Lin, Feng-Huei; Lin, Chien-Cheng; Young, Tai-Horng; Shieh, Ming-Jium |
| 臺大學術典藏 |
2020-02-26T01:33:26Z |
Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
|
Feng-Huei LinTseng, C.-L.;Wu, S.Y.-H.;Wang, W.-H.;Peng, C.-L.;Lin, F.-H.;Lin, C.-C.;Young, T.-H.;Shieh, M.-J.; Tseng, C.-L.; Wu, S.Y.-H.; Wang, W.-H.; Peng, C.-L.; Lin, F.-H.; Lin, C.-C.; Young, T.-H.; Shieh, M.-J.; FENG-HUEI LIN |
| 臺大學術典藏 |
2020-02-27T03:57:26Z |
Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
|
Lin F.-H; Lin C.-C; Tai-Horng Young; Shieh M.-J.; Tseng C.-L;Wu S.Y.-H;Wang W.-H;Peng C.-L;Lin F.-H;Lin C.-C;Tai-Horng Young;Shieh M.-J.; Tseng C.-L; Wu S.Y.-H; Wang W.-H; Peng C.-L |
| 國立交通大學 |
2019-04-02T05:58:20Z |
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
|
Liao, Wei-Siang; Ho, Yu; Lin, Yu-Wei; Raj, Emmanuel Naveen; Liu, Kuang-Kai; Chen, Chinpiao; Zhou, Xiao-Zhen; Lu, Kun-Ping; Chao, Jui-I |
| 中國醫藥大學 |
2015-10 |
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
|
(Hsieh YH);(Hsieh SC);李建興(Chien-Hsin Lee);(Yang SF);(Cheng CW);(Tang MJ);(Chia-Liang Lin);(Lin CL);鄒瑞煌(Ruey-Hwang Chou)* |
| 國立成功大學 |
2019-12-17 |
Targeting Endogenous Adduction Level of Serum Albumin by Parallel Reaction Monitoring via Standard Additions and Intact Protein Measurement: Biological Dosimetry of Catechol Estrogens
|
Huang;Yu-Shan;Lin;Yu-Min;Chen;Hsin;Wu;Chih-Hsing;Syu;Chong-Hua;Huang;Ting-En;Do;Quynh-Trang;Chen;Shu-Hui |
| 臺大學術典藏 |
2008 |
Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih; Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih |
| 國立臺灣大學 |
2008 |
Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih |
| 臺大學術典藏 |
2018-09-10T08:29:51Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin, S.-L. and Chang, F.-C. and Schrimpf, C. and Chen, Y.-T. and Wu, C.-F. and Wu, V.-C. and Chiang, W.-C. and Kuhnert, F. and Kuo, C.J. and Chen, Y.-M. and Wu, K.-D. and Tsai, T.-J. and Duffield, J.S.; VIN-CENT WU; SHUEI-LIONG LIN; TUN-JUN TSAI; WEN-CHIH CHIANG; YUNG-MING CHEN |
| 臺大學術典藏 |
2020-09-28T07:05:02Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Duffield J.S.; Tsai T.-J.; Wu K.-D.; Chen Y.-M.; Kuo C.J.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Chiang W.-C.; Kuhnert F. |
| 臺大學術典藏 |
2011 |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Yung-Ming Chen;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; YUNG-MING CHEN; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2011 |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Schrimpf C.; Chang F.-C.; Lin S.-L.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; TUN-JUN TSAI; Duffield J.S. |
| 臺大學術典藏 |
2020-12-24T08:38:29Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
WEN-CHIH CHIANG; Wu V.-C.; Chen Y.-T.; Wu C.-F.; Schrimpf C.; Chang F.-C.; Lin S.-L.; Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Wen-Chih Chiang;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Duffield J.S.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-23T02:58:02Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Tsai T.-J.; Wu K.-D.; Chen Y.-M.; Kuo C.J.; Kuhnert F.; Chiang W.-C.; Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Vin-Cent Wu;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; VIN-CENT WU; Duffield J.S. |
| 臺大學術典藏 |
2021-08-23T03:44:00Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; FAN-CHI CHANG; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-08-23T23:47:26Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; Chang F.-C.; Schrimpf C.; YI-TING CHEN; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-11-30T04:54:30Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; VIN-CENT WU; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-01-12T03:32:22Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Shuei-Liong Lin;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; SHUEI-LIONG LIN; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 國立臺灣大學 |
2011 |
Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple- Negative Breast Cancer by a Novel Adenosine Monophosphate-Activated Protein Kinase (Ampk) Activator
|
顧記華; 楊小青; 陳慶士; GUH, JIH-HWA; YANG, HSIAO-CHING; CHEN, CHING-SHIH |
| 臺大學術典藏 |
2021-06-02T05:43:48Z |
Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator
|
Lee K.-H.; Hsu E.-C.; JIH-HWA GUH; Yang H.-C.; Wang D.; Kulp S.K.; Shapiro C.L.; Chen C.-S. |
| 臺大學術典藏 |
2021-06-04T03:09:10Z |
Targeting ENT1 and adenosine tone for the treatment of Huntington's disease
|
Kao Y.-H.;Lin M.-S.;Chen C.-M.;Wu Y.-R.;Chen H.-M.;Lai H.-L.;Chern Y.;Chun-Jung Lin; Kao Y.-H.; Lin M.-S.; Chen C.-M.; Wu Y.-R.; Chen H.-M.; Lai H.-L.; Chern Y.; CHUN-JUNG LIN |
| 臺北醫學大學 |
2006 |
Targeting epidermal growth factor receptor in lung cancer: Perspective from the Asia–Pacific region
|
劉興璟; Liu HE; Lim KH; Huang MJ; Huang BS |
| 國立臺灣大學 |
2013 |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai, Yu-Chieh; Yeh, Chih-Hsien; Tzen, Kai-Yuan; Ho, Pei-Yin; Tuan, Tsung-Fan; Pu, Yeong-Shiau; Cheng, Ann-Lii; Cheng, Jason Chia-Hsien; 蒲永孝; 曾凱元; 鄭安理; 成佳憲; 蔡育傑; 何蓓茵 |
| 臺大學術典藏 |
2021-02-02T00:46:32Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Yu-Chieh Tsai;Yeh C.-H.;Tzen K.-Y.;Ho P.-Y.;Tuan T.-F.;Pu Y.-S.;Cheng A.-L.;Cheng J.C.-H.; YU-CHIEH TSAI; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:49Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; ANN-LII CHENG; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-18T05:59:06Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; KAI-YUAN TZEN; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-09-16T03:41:20Z |
Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling
|
Hung C.-T.; Su T.-H.; Chen Y.-T.; Wu Y.-F.; Chen Y.-T.; SUNG-JAN LIN; Lin S.-L.; Yang K.-C. |
| 國立成功大學 |
2024-10 |
Targeting ferroptosis by natural products in pathophysiological conditions
|
Zheng;Daheng;Jin;Shikai;Liu;Pu-Ste;Ye;Jianping;Xie;Xin |
| 臺大學術典藏 |
2020-03-02T07:45:08Z |
Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity
|
Wu H.-T.;Chen S.-C.;Fan K.-C.;Kuo C.-H.;Lin S.-Y.;Shu-Huei Wang;Chang C.-J.;Li H.-Y.; Wu H.-T.; Chen S.-C.; Fan K.-C.; Kuo C.-H.; Lin S.-Y.; SHU-HUEI WANG; Chang C.-J.; Li H.-Y. |
| 臺大學術典藏 |
2020-06-01T06:31:22Z |
Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity
|
Wu H.-T.;Chen S.-C.;Fan K.-C.;Kuo C.-H.;Lin S.-Y.;Wang S.-H.;Chang C.-J.;Hung-Yuan Li; Wu H.-T.; Chen S.-C.; Fan K.-C.; Kuo C.-H.; Lin S.-Y.; Wang S.-H.; Chang C.-J.; HUNG-YUAN LI |
| 臺大學術典藏 |
2020 |
Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity
|
KANG-CHIH FAN; Wu, Hung-Tsung ; Chen, Szu-Chi ; Kuo, Chun-Heng ; Lin, Shin-Yu ; Wang, Shu-Huei ; Chang, Chih-Jen ; Li, Hung-Yuan |
| 臺大學術典藏 |
2021-03-10T03:11:22Z |
Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity
|
Wu H.-T.;Chen S.-C.;Kang-Chih Fan;Kuo C.-H.;Lin S.-Y.;Wang S.-H.;Chang C.-J.;Li H.-Y.; Wu H.-T.; Chen S.-C.; KANG-CHIH FAN; Kuo C.-H.; Lin S.-Y.; Wang S.-H.; Chang C.-J.; Li H.-Y. |
| 臺大學術典藏 |
2021-03-02T06:21:25Z |
Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity
|
Wu H.-T.;Chen S.-C.;Fan K.-C.;Kuo C.-H.;Shin-Yu Lin;Wang S.-H.;Chang C.-J.;Li H.-Y.; Wu H.-T.; Chen S.-C.; Fan K.-C.; Kuo C.-H.; SHIN-YU LIN; Wang S.-H.; Chang C.-J.; Li H.-Y. |
| 國立成功大學 |
2020 |
Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity
|
Wu, H.-T.;Chen, S.-C.;Fan, K.-C.;Kuo, C.-H.;Lin, S.-Y.;Wang, S.-H.;Chang, Chang C.-J.;Li, H.-Y. |
| 臺北醫學大學 |
2015-12 |
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
|
林雨樵 |
| 臺大學術典藏 |
2021-01-12T03:32:01Z |
Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
|
Pai C.-H.;Lin S.-R.;Liu C.-H.;Pan S.-Y.;Hsu H.;Chen Y.-T.;Yen C.-T.;Yu I.-S.;Wu H.-L.;Shuei-Liong Lin;Lin S.-W.; Pai C.-H.; Lin S.-R.; Liu C.-H.; Pan S.-Y.; Hsu H.; Chen Y.-T.; Yen C.-T.; Yu I.-S.; Wu H.-L.; SHUEI-LIONG LIN; Lin S.-W. |
| 臺大學術典藏 |
2021-03-11T08:12:06Z |
Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
|
Pai, Chen-Hsueh; Lin, Shu-Rung; Liu, Chia-Hao; Pan, Szu-Yu; Hsu, Hao; Chen, Yi-Ting; Yen, Ching-Tzu; Yu, I-Shing; Wu, Hua-Lin; Lin, Shuei-Liong; SHU-WHA LIN |
| 臺大學術典藏 |
2021-08-23T23:47:18Z |
Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
|
Pai C.-H.; Lin S.-R.; Liu C.-H.; Pan S.-Y.; Hsu H.; YI-TING CHEN; Yen C.-T.; Yu I.-S.; Wu H.-L.; Lin S.-L.; Lin S.-W. |
| 國立成功大學 |
2020 |
Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
|
Pai, C.-H.;Lin, S.-R.;Liu, C.-H.;Pan, S.-Y.;Hsu, Hsu H.;Chen, Y.-T.;Yen, C.-T.;Yu, I.-S.;Wu, H.-L.;Lin, S.-L.;Lin, S.-W. |
| 臺大學術典藏 |
2021-03-09T05:18:34Z |
Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma
|
Cheng A.-L.; Ying-Chun Shen; Zhu A.X. |
| 臺大學術典藏 |
2021-09-01T01:54:03Z |
Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma
|
ANN-LII CHENG; Shen Y.-C.; Zhu A.X. |
| 國立臺灣海洋大學 |
2016-06 |
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer
|
Chen-Hung Ting; Yi-Chun Chen; Chang-Jer Wu; Jyh-Yih Chen |
| 國立成功大學 |
2016-09-27 |
Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma
|
Hsu, I-Ling; Chou, Cheng-Yang; Wu, Yi-Ying; Wu, Jia-En; Liang, Chen-Hsien; Tsai, Yao-Tsung; Ke, Jhen-Yu; Chen, Yuh-Ling; Hsu, Keng-Fu; Hong, Tse-Ming |
| 國立成功大學 |
2011-03-15 |
Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression
|
Wu, Ming-Heng; Hong, Hsiao-Chin; Hong, Tse-Ming; Chiang, Wei-Fan; Jin, Ying-Tai; Chen, Yuh-Ling |
| 亞洲大學 |
2022-06-01 |
Targeting glycolysis in Th2 cells by pterostilbene attenuates clinical severities in an asthmatic mouse model and IL-4 production in peripheral blood from asthmatic patients
|
劉傳騰;Liu, Chuan-Teng;宋瑛琪;Song, Ying-Chyi;吳采真;Shi, Ko-Chieh;Shiung, Ko-Chieh;Chen, I-Hsuan;Chen, I-Hsuan;張東?;Chang, Tung-Ti;梁信杰;Liang, Shinn-Jye;顏宏融 |
| 臺大學術典藏 |
2018-09-10T18:05:02Z |
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
|
Tsai, C.-L. and Liu, W.-L. and Hsu, F.-M. and Yang, P.-S. and Yen, R.-F. and Tzen, K.-Y. and Cheng, A.-L. and Chen, P.-J. and Cheng, J.C.-H.; RUOH-FANG YEN; KAI-YUAN TZEN; ANN-LII CHENG |
| 臺大學術典藏 |
2021-03-18T05:58:56Z |
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
|
Tsai C.-L.; Liu W.-L.; Hsu F.-M.; Yang P.-S.; Yen R.-F.; KAI-YUAN TZEN; Cheng A.-L.; Chen P.-J.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:31Z |
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
|
Tsai C.-L.; Liu W.-L.; Hsu F.-M.; Yang P.-S.; Yen R.-F.; Tzen K.-Y.; ANN-LII CHENG; Chen P.-J.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-05-21T07:17:44Z |
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
|
CHIAO-LING TSAI; Liu W.-L.; Hsu F.-M.; Yang P.-S.; Yen R.-F.; Tzen K.-Y.; Cheng A.-L.; Chen P.-J.; Cheng J.C.-H. |
